From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

HAYD
premium content

Haydale – Grim Trading Statement means SELL; has it contravened AIM Rules?

AIM-listed Haydale Graphene Industries (HAYD) offered up a pretty grim trading statement this morning showing that sales at its US unit were materially below those of H1 2019 during H1 2020. Oopsie. Meanwhile UK operations suffered from longer than anticipated lead times and sales fell short of directors’ expectations. Double oopsie. And the company has shuttered its Taiwan operation which will lead to a revenue shortfall in H2 of around £0.4 million. Triple oopsie – and now we are told that full year sales will come in below market expectations (whatever they are). What’s not to like?!

JHD

James Halstead – emphasises delivering “record pre-tax profit”… but value?

Commercial flooring manufacturer and distributor, James Halstead (JHD) has updated including “the company expects to report record pre-tax profit for the half-year… Turnover in the UK was 6.8% ahead of the prior year, a creditable performance against the prevailing market conditions. Underlying margins held up”. The shares have though failed to respond positively…

OPTI
premium content

4 pieces of Optibiotix news but only 2 announced – I have never been so bullish

I am now a customer as well as a shareholder having ordered two boxes of Slimbiome to help me shift, ahem, a few pounds. I shall report back on my progress. But you want to gain pounds don’t you? Well at a 60p offer, the way to do that is to buy more Optibiotix (OPTI) shares. I have as I have never been more confident about the company and its prospects. Let me explain why with reference to the four bits of news out this week...

BIOM

Biome Technologies – emphaises substantial bioplastics growth, BUT…

Previously writing on bioplastics and radio frequency technology company Biome Technologies (BIOM), I concluded on its third quarter trading update with the shares at 285p that it’s forget “being closer” to £4 million than £7 million, it’s just “in line” with £4 million – and even that requiring smooth delivery… for now certainly continue to avoid. That referred to radio frequency technology division revenue and now… “Trading statement and Board change”

VAST
premium content

Vast Resources - the death spiral cheque is in the post. Honest! Fatty says it is!

Only the laziest, stupidest and most credulous of Nomads would have signed off on the death spiral funding releases issued over the past few months by, almost certainly worthless, Vast Resources (VAST). Luckily Vast employs Roland "fatty" Cornish  and so today we get another update. You may remember... 

AVCT

Avacta - It Gets Even Better

Hello, Share Speakers. If you’d acted on my Avacta (AVCT) commendation yesterday you’d be up by nearly 20% already. But I still think there’s a chance to make some more on this interesting share. What I didn’t have time to analyse yesterday was the latest trading update – which makes jolly reading...

OPTI
premium content

Photo Article – Slimbiome arrives at Welsh hovel but what are the margins for Optibiotix & why no RNS on mega US News

The photos below show the two boxes of Slimbiome that arrived today at the Welsh Hovel and also one of the sachets, 21 of which sit in each box. I have used a standard loo roll in the pictures to give you an indication of size.

Bearcast
premium content

Tom Winnifrith Bearcast - My Slimbiome arrives this afternoon

In today's podcast I discuss Optibiotix (OPTI), how the critics have moved the goalposts and the ghastly Daily Mail. I also look at Big Dish (DISH) where ennui is setting in, at misleading interims from the worthless cur that is Plutus Powergen (PPG), at serial confetti issuer Zenith Energy (ZEN) and then at Eurasia Mining (EUA) where, after this post, I should say Optiva is now denying it is doing a placing. But frankly, it's still a matter of when not if.

FAB

Fusion Antibodies – emphasises “strong revenue performance”… what about cash burn?

Previously I’ve cautioned on shares in “specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications”, Fusion Antibodies (FAB). They have recently though again been rising – and today a “Trading update”

QXT
premium content

Quixant – I could anticipate the further “softness in demand”, so why didn’t the company?

Previously writing on self-styled “a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries” Quixant (QXT), in September with the shares slumping to just over 160p I questioned were even reduced forecasts realistic given customers have informed that order levels will not return to previous levels through “at least” the first half of 2020. Now a “Trading Update”

FUTR
premium content

Major Expose Part 3 of the Future house built on sand – Obscene executive greed & Mark Slater’s financial virtue signalling

Britain's tiop fund manager, my pal Mark Slater, has said that he will vote down annual reports where he sees unacceptable executive greed yet his largest holding is Future (FUTR) which not only has major fundamental “funnies” but is a case study in obscene executive greed.

EUA

Bulletin Board Moron of the week is spotted by Evil Banksta, thanks again to Eurasia Mining

At 3.4p Eurasia Mining (EUA) is a company shown to have lied to investors, with zero balance sheet support and which is burning cash. That is why, it needs to do a placing. Yet it is still capitalised at £92 million. So, what are the shares worth?  I asked you for the craziest examples of Bulletin Board Moron madness last week and while there were some great spots as you can see HERE, Evil Banksta came up with the gem below:

Newsboy
premium content

Whilst SCS contracts, Quilter migrates...

Back in November I had a bit of fun at the expense of the 'upholstered furniture and floorings' company ScS (SCS)observing how bonkers some of its comments had been. Today's half-year trading update has its moments too, even though it claims to be 'in line with the Board's expectations'…

TERN
premium content

Tern – portfolio update: but what about the Elephant in the room, Device Authority?

AIM-listed jam-tomorrow (or never…) investment company Tern plc (TERN) has updated the market with a portfolio review. The news seems good (a big contract for one investee and a fair investment for another) but the elephant in the room is its investment in Device Authority Limited – on which we learn precisely nothing. Worse still, apparently Tern now has a genuinely diversified portfolio of…. companies, with each……having a disruptive technology in a global market. Oh dear: it's that word again, 'disruptive' – has the board not heard of what happened to Neil Woodford?!

AVCT

Phew! My Priority Penny Share Tip Scorches Ahead on a Successful New Trial

Hello Share People. It’s all looking chipper for medical pioneer Avacta (AVCT). When Tom interviewed me fairly recently for his scintillating radio podcast, I gave this company the dubious award as my favourite penny share. And so far, luckily, I am proving right. The latest news is pretty exciting and, as I write, has propelled the share up by 15%...

TRX

Tissue Regenix – from bad to worse for Woodford investors here…

An announcement from Tissue Regenix (TRX), a Woodford pick (uh oh), at an intra-day 10:02am (uh oh); “Notice of cyber security incident”. Oh dear! – and particularly considering the company’s previous announcement included that it only “believes that the available cash runway will continue to support the working capital requirement of the company until the end of April 2020”!...

Newsboy
premium content

Why value investors should buy PZ Cussons and not Crest Nicholson

It is always striking to me that even experienced investors feel the burn when the market goes down a little bit more than on any day in the last four or six months. I know that pension values, spread bet positions, public tipster perception and much more rest on the fluctuations of the world's financial markets, but the real money is being a thoughtful weighing machine investor and not a finger-on-the-trigger voting machine one. Well that is my perception at least and why I included this wonderful quote from James Lovelock (‘An inefficient virus kills its host. A clever virus stays with it’) in some musings I had to send over the other side of the Pond. In short, if you are worried about the coronavirus, then you should be petrified about the alternative financial disease that packages itself up as personal, corporate or government debt burdens. Talking about debt…

SJH
premium content

St James House: Its Doomsday Clock is at 30 seconds to midnight

On 6 December 2019, AIM uber dog St James House  (SJH) issued a trading update indicating more losses for second half of the year ending on 31 January 2020.  It also stated it was actively exploring options to improve the working capital position of the group before the end of its current financial year end on 31 January 2020 as it was working capital constrained.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 15:08:09